NRAS mutant melanoma – undrugable?
NRAS mutant melanoma – undrugable? |
|
https://doi.org/10.18632/oncotarget.970
Christian Posch,
and Susana Ortiz-Urda
|
| 494-495 |
New activities for the anti-tumor agent trabectedin: taking two birds with one stone
New activities for the anti-tumor agent trabectedin: taking two birds with one stone |
|
https://doi.org/10.18632/oncotarget.968
Maurizio D’Incalci,
Roberta Frapolli,
Giovanni Germano,
and Paola Allavena
|
| 496-497 |
Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion
Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion |
|
https://doi.org/10.18632/oncotarget.979
Derek C Radisky,
and Celeste M Nelson
|
| 498-499 |
Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha.
Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha. |
|
https://doi.org/10.18632/oncotarget.986
Steven W Lane,
and Ann Mullally
|
| 500-501 |
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. |
|
https://doi.org/10.18632/oncotarget.969
Richard E. Kast,
John A. Boockvar,
Ansgar Brüning,
Francesco Cappello,
Wen-Wei Chang,
Boris Cvek,
Q Ping Dou,
Alfonso Duenas-Gonzalez,
Thomas Efferth,
Daniele Focosi,
Seyed H. Ghaffari,
Georg Karpel-Massler,
Kirsi Ketola,
Alireza Khoshnevisan,
Daniel Keizman,
Nicolas Magné,
Christine Marosi,
Kerrie McDonald,
Miguel Muñoz,
Ameya Paranjpe,
Mohammad H. Pourgholami,
Iacopo Sardi,
Avishay Sella,
Kalkunte S. Srivenugopal,
Marco Tuccori,
Weiguang Wang,
Christian R. Wirtz,
and Marc-Eric Halatsch
|
| 502-530 |
Effects of CT-Xp Gene Knock down in Melanoma Cell Lines
Effects of CT-Xp Gene Knock down in Melanoma Cell Lines |
|
https://doi.org/10.18632/oncotarget.921
Otavia Luisa Caballero,
Tzeela Cohen,
Sita Gurung,
Ramon Chua,
Peishan Lee,
Yao-Tseng Chen,
Parmjit Jat,
Lloyd J. Old,
and Andrew J. G. Simpson
|
| 531-541 |
Galectin-3: a possible complementary marker to the PSA blood test
Galectin-3: a possible complementary marker to the PSA blood test |
|
https://doi.org/10.18632/oncotarget.923
Vitaly Balan,
Yi Wang,
Pratima Nangia-Makker,
Dhonghyo Kho,
Madhuri Bajaj,
Daryn Smith,
Lance Heilbrun,
Avraham Raz,
and Elisabeth Heath
|
| 542-549 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia |
|
https://doi.org/10.18632/oncotarget.939
Yukari Ishiguro,
Hitoshi Ishiguro,
and Hiroshi Miyamoto
|
| 550-559 |
Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α′: implications for pathological roles of CK2 in promoting cancer cell survival.
Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α′: implications for pathological roles of CK2 in promoting cancer cell survival. |
|
https://doi.org/10.18632/oncotarget.948
Jacob P Turowec,
Greg Vilk,
Michelle Gabriel,
and David W Litchfield
|
| 560-571 |
Exomic Sequencing of Four Rare Central Nervous System Tumor Types
Exomic Sequencing of Four Rare Central Nervous System Tumor Types |
|
https://doi.org/10.18632/oncotarget.964
Chetan Bettegowda,
Nishant Agrawal,
Yuchen Jiao,
Yuxuan Wang,
Laura D. Wood,
Fausto J. Rodriguez,
Ralph H. Hruban,
Gary L. Gallia,
Zev A. Binder,
Callen J. Riggins,
Vafi Salmasi,
Gregory J. Riggins,
Zachary J. Reitman,
Ahmed Rasheed,
Stephen Keir,
Sueli Shinjo,
Suely Marie,
Roger McLendon,
George Jallo,
Bert Vogelstein,
Darrell Bigner,
Hai Yan,
Kenneth W. Kinzler,
and Nickolas Papadopoulos
|
| 572-583 |
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene |
|
https://doi.org/10.18632/oncotarget.965
Arnaldur Hall,
Kathrine Damm Meyle,
Marina Krarup Lange,
Martin Klima,
May Sanderhoff,
Christina Dahl,
Cecilie Abildgaard,
Katrine Thorup,
Seyed Moein Moghimi,
Per Bo Jensen,
Jiri Bartek,
Per Guldberg,
and Claus Christensen
|
| 584-599 |
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group |
|
https://doi.org/10.18632/oncotarget.918
Ketan Badani,
Darby J.S. Thompson,
Christine Buerki,
Elai Davicioni,
Jill Garrison,
Mercedeh Ghadessi,
Anirban P. Mitra,
Penelope J. Wood,
and John Hornberger
|
| 600-609 |
Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer
Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer |
|
https://doi.org/10.18632/oncotarget.934
Alka Mukhopadhyay,
Thaer Khoury,
Leighton Stein,
Protul Shrikant,
and Ashwani K. Sood
|
| 610-621 |
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms |
|
https://doi.org/10.18632/oncotarget.938
Mark J Axelrod,
Vicki Gordon,
Mark Conaway,
Adel Tarcsafalvi,
Daniel J Neitzke,
Daniel Gioeli,
and Michael J Weber
|
| 622-635 |
Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma
Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma |
|
https://doi.org/10.18632/oncotarget.950
Marcelo R.P. Freitas,
Suzana M.F. Malheiros,
João N. Stávale,
Thaís P. Biassi,
Fernando T. Zamunér,
Maria D.F.S. Begnami,
Fernado A. Soares,
and André L. Vettore
|
| 636-646 |
